Magnetic Resonance Imaging Market to Witness Growth Due to The Increasing Demand for Scans
The prevalence of cardiovascular and oncology diseases and the shortage of radiologists have boosted the development of innovative MRI technologies SAN ANTONIO, Dec. 19, 2022 /PRNewswire/ -- The traditional magnetic resonance imaging (MRI) approach is being disrupted by portable MRI systems, open design MRI systems, advanced metamaterials, and integration of artificial intelligence (AI) and advanced software technologies. The rising...
SmartFuture Launches First Responder Platform
SINGAPORE, Dec. 19, 2022 /PRNewswire/ -- As a key addition to its portfolio of Remote Patient Monitoring (RPM) solutions, SmartFuture has launched a First Responder Platform. This is an integrated solution designed for rapid response through real time monitoring of health vitals, doctor consultation and timely action during emergency situations. The Platform consists of (a) a First Responder Kit consisting...
Clinical Trial Approval For The Company’s Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines
TAIZHOU, China, Dec. 19, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Group has recently received the clinical trial approval for its novel adjuvanted recombinant shingles vaccine, REC610, from the Food and Drug Administration of the Philippines....
Mahidol University Created VR Contents for Teaching Skills of Infectious Disease Treatment and Held a Remote VR Seminar for Japanese Medical Students Connecting Thailand and Japan
Collaborative Development of Infectious Disease Education VR with Jolly Good and Juntendo University TOKYO, Dec. 19, 2022 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji, hereinafter referred to as "Jolly Good") held a bilateral medical VR seminar connecting Thailand and Japan at JITMM 2022, an international medical conference, utilizing VR teaching materials (*) developed in collaboration with Royal...
‘NCDs in Focus Act Now’ Summit organized by Viatris
The summit aimed to build synergies between healthcare professions and policy makers, addressing the challenges in the management of NCDs in Southeast Asia BANGKOK, Dec. 19, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS): The 'NCDs in Focus Act Now' Summit was recently organised by global healthcare company, Viatris, in collaboration with the...
Education Cannot Wait Receives Mother Teresa Memorial Award for Social Justice 2022
"On behalf of the 222 million crisis-affected girls and boys worldwide who urgently need education support, I am honored and humbled to accept the Mother Teresa Memorial Award for Social Justice." – ECW Director Yasmine Sherif MUMBAI, India, Dec. 18, 2022 /PRNewswire/ -- The Harmony Foundation awarded Education Cannot Wait – the United Nations...
TG ImmunoPharma (TGI) announces FDA clearance of IND application for TGI-2, a novel anti-PVRIG therapeutic antibody
HEFEI, China, Dec. 17, 2022 /PRNewswire/ -- TG ImmunoPharma Co., Ltd. (Hefei, China), an innovative biotech company dedicated to the discovery of novel immunotherapeutic drugs and a leader in NK cell research globally, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for TGI-2/NM1F, a novel anti-PVRIG therapeutic antibody used...
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform Cancer genomics testing is now standard practice for cancer care and has shown to be highly successful such as Foundation One (acquired by Roche), Grail (acquired by Illumina), Exact Sciences, Guardant Health and more Expects ACT to contribute US$25-30 million...
Possible Breakthrough in Cardiovascular Disease Diagnostics for the United States
SINGAPORE, Dec. 16, 2022 /PRNewswire/ -- Neuome Peptides Pte. Ltd., a Singapore-based company has established an assay-development platform, powered by machine learning and novel, patented algorithms for the quantifiable detection of biomarkers. The company successfully designed specific peptides to bind to pre-established, proven biomarkers for Cardiovascular Diseases and...
Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia
SINGAPORE, Dec. 16, 2022 /PRNewswire/ -- Neuome Peptides Pte. Ltd., a Singapore-based company has established an assay-development platform, powered by machine learning and novel, patented algorithms for the quantifiable detection of biomarkers. The company successfully designed specific peptides to bind to pre-established, proven biomarkers for Cardiovascular Diseases and...
